Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.20%
#3 Glidr Glidr +36.87%
#4 CoW Protocol CoW Protocol +35.84%
#5 RedStone RedStone +30.12%
#6 Humanity Humanity +25.83%
#7 Codatta Codatta +22.98%
#8 Walrus Walrus +19.40%
#9 Enso Enso +18.53%
#10 The Black Bull The Black Bull +18.16%
Coin of the day
EXOD EXOD
設定
言語
日本
通貨
USD
テーマ
Jupiter Neurosciences, Inc. Jupiter Neurosciences, Inc.

Jupiter Neurosciences, Inc.

JUNS
株式のランク #36527
Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in... Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in clinical-stage research and development. Its primary focus is on advancing a resveratrol-based platform product, with the main objective of addressing neuro-inflammation. The company's pipeline includes several drug candidates: JNS101 is undergoing Phase II trials for Friedreich's Ataxia, a rare neurological disorder that damages the nervous system and causes mobility issues. Also in Phase II, JNS102 is being developed for mucopolysaccharidosis Type I, JNS107 for MELAS Syndrome, and JNS108 for mild cognitive impairment and early Alzheimer's disease. Furthermore, the company is progressing JNS109 for amyotrophic lateral sclerosis, JNS110 for traumatic brain injury and concussion, and JNS120 as a treatment for COVID-19. Founded in 2016, the company, formerly known as Jupiter Orphan Therapeutics, Inc., adopted its current name in August 2021 and is headquartered in Jupiter, Florida.
株価
$5.34
最終同期: 2026-08-14
時価総額
$2.59M
変化（1日）
-11.00%
変化（1年）
313.95%
国
US
取引 Jupiter Neurosciences, Inc. (JUNS)

カテゴリー

Healthcare
Jupiter Neurosciences, Inc.（JUNS）の株価履歴
終値の最高値: $4.45 （2026-08-01）

終値の最安値: $10.06 （2024-12-01）
Jupiter Neurosciences, Inc. の株価履歴（2024 ～ 2026）
年間株価パフォーマンス
年 パフォーマンス
2026 (TTM) -20.40%
2025 -88.77%
2024 0.00%
類似企業または競合の株価
企業 株価 変化率 1年% 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE